Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function.
Vincent
A
A
Department of Clinical Neurology, University of Oxford, United Kingdom.
Li
Z
Z
Hart
A
A
Barrett-Jolley
R
R
Yamamoto
T
T
Burges
J
J
Wray
D
D
Byrne
N
N
Molenaar
P
P
Newsom-Davis
J
J
D000109:Acetylcholine / Q000378:metabolism; D001323:Autoantibodies / Q000276:immunology; D002217:Carbachol / Q000494:pharmacology; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D015640:Ion Channel Gating; D008297:Male; D009157:Myasthenia Gravis / Q000097:blood / Q000276:immunology / Q000503:physiopathology*; D009469:Neuromuscular Junction / Q000502:physiology; D011978:Receptors, Nicotinic / Q000276:immunology / Q000502:physiology*; D012964:Sodium / Q000378:metabolism; D009435:Synaptic Transmission
D001323:Autoantibodies; D011978:Receptors, Nicotinic; D002217:Carbachol; D012964:Sodium; D000109:Acetylcholine